ALPINE GLOBAL MANAGEMENT, LLC – CytomX Therapeutics, Inc. Transaction History
ALPINE GLOBAL MANAGEMENT, LLC portfolio value:
$17,000
portfolio value
ALPINE GLOBAL MANAGEMENT, LLC quarter portfolio value change:
-20.77%
quarter
CytomX Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -5K | $1.45 | 11.8K | |
| Q2 2022 | share | 0.00% | 0 shares | -10K | $1.83 | 11.8K | |
| Q1 2022 | share | Decrease | -46.81% | -10.38K shares | -64K | $2.67 | 11.8K |
| Q4 2021 | share | Increase | 0.00% | 22.18K shares | 96K | $4.4 | 22.18K |
| Q1 2020 | share | Decrease | -100.00% | -32.89K shares | -273K | $7.67 | 0 |
| Q4 2019 | share | Increase | 0.00% | 32.89K shares | 273K | $8.31 | 32.89K |